Clinical Research Directory
Browse clinical research sites, groups, and studies.
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis
Sponsor: The National Brain Mapping Laboratory (NBML)
Summary
Multiple Sclerosis (MS) is an autoimmune disease associated with physical disability, psychological impairment, and cognitive dysfunction. As a result, the disease burden is high, and treatment options are limited. In this randomized, double-blind study, the investigators planned to use repeated electrical stimulation and assess mental health-related variables (e.g., quality of life, sleep, psychological distress) and cognitive dysfunction in patients with MS.
Official title: Electrical Brain Stimulation for Improving Mental Health and Cognitive Functioning in Patients With Multiple Sclerosis
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
53
Start Date
2023-02-28
Completion Date
2024-01-31
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
transcranial direct current stimulation
Patients will receive 10 sessions of either 1.5 mA electrical stimulation for 20 minutes each day over 10 consecutive days.
transcranial direct current stimulation combined with cognitive training
Patients will receive 10 sessions of 20 minutes of 1.5 mA electrical stimulation on 10 consecutive days. Each session is followed by 30 minutes cognitive training in which patients conduct several computerized cognitive tests.
transcranial direct current stimulation
Patients will receive 10 sessions of sham (placebo) electrical stimulation for 20 minutes each day over 10 consecutive days.
Locations (1)
Multiple Sclerosis Association of Guilan
Rasht, Giulan, Iran